Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 04, 2021 17:34 ET | Source: Telix Pharmaceuticals Limited

First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer

MELBOURNE, Australia and LIÈGE, Belgium, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a first patient has been dosed...
August 17, 2021 21:26 ET | Source: Telix Pharmaceuticals Limited

Two New Studies to Explore Telix Assets in Breast Cancer Theranostics

Breast cancer one of several important indication expansion opportunities for the Telix portfolioFirst patient dosed at Emory University (Atlanta, USA) in a Phase I study of TLX591-CDx for the staging...